Transdermal Scopolamine Market Research Report by Geographical Analysis and Forecast to 2024

In this research report, the worldwide market for transdermal scopolamine is primarily analyzed on the basis of its geographical presence. As per the study, Latin America, North America, the Middle East and Africa, Europe, and Asia Pacific are the primary geographical segments of this market. North America, among these, has emerged as key contributor to this market, thanks to the presence of an advanced healthcare industry. Driven by the high healthcare expenditure and increased usage of transdermal scopolamine in surgeries and post-operative recovery, this regional market is likely to remain dominant throughout the forecast period, rising at a 6.40% CAGR.

Although the North America market will retain its position, the market stagnancy caused by the availably of limited generics is expected to reflect negatively on its growth rate in the near future. Europe, on the other hand, is anticipated to witness a significant rise in its transdermal scopolamine market in the years to come, thanks to the presence of a state-of-art healthcare industry and the rising pool of travelers. Western Europe is projected to surface as the key domestic market in the European market for transdermal scopolamine over the next few years.

Among other regional markets, Asia Pacific is projected to offer lucrative growth opportunities to market players in the near future on the grounds of the rising expenditure on healthcare, infrastructural advancements in the healthcare industry, and the growing focus on community healthcare in developing markets, such as China and India, reports the research study.

This 103 page report gives readers a comprehensive overview of the Transdermal Scopolamine Market. Browse through 7 data tables and 15 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/transdermal-scopolamine-market.html

The increasing awareness among consumers pertaining to the high efficiency of transdermal scopolamine in treating motion sickness is influencing the global market for transdermal scopolamine substantially, says a TMR analyst. With the increasing number of travelers across the world, the cases of motion sickness are on a rise, reflecting positively on the demand for transdermal scopolamine patches, globally.

Since these patches are also utilized while surgeries to prevent hyper salivation and to speed-up the recovery from post-operative and anesthesia induced vomiting and nausea, the upswing in the number of surgeries performed worldwide is likely to boost the global transdermal scopolamine market considerably over the forecast period. However, the increasing reports of side-effects caused by these patches, such as retarted motion, drowsiness, and diluted pupils, may restrict their usage to some extent in the coming years. Beside this, the enforcement of strict norms and regulations in manufacturing and marketing of transdermal scopolamine patches and products may also hinder the growth of this market over the next few years, states the report.

The study presented here is based on a report by Transparency Market Research (TMR), titled “Transdermal Scopolamine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Get accurate market forecast and analysis on the Transdermal Scopolamine Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=22322

With the increasing expenditure on healthcare, infrastructural developments in the healthcare industry, and the rising emphasis on community healthcare in emerging economies, such as China and India, Asia Pacific is expected to provide the most promising growth opportunities to players in the near future. The number of small- and medium- scale players, offering their transdermal scopolamine patches in this region, has increased substantially, making a competitive environment, which is likely to drive the Asia Pacific market for transdermal scopolamine further in the years to come. Amongst other, Latin America and the Middle East and Africa are anticipated to witness steady growth in their markets for transdermal scopolamine over the coming years, thanks to the rising number of travelers and the increasing focus of key industry players on these regions.

Baxter International Inc., GlaxoSmithKline Plc, Novartis AG, Perrigo Co. Plc, Caleb Pharmaceuticals Inc, and Myungmoon Pharma Co. Ltd. are the leading players operational in the global transdermal scopolamine market.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.